A rare cause of obstructive jaundice: Fasciola hepatica mimicking cholangiocarcinoma

Turkish Journal of Gastroenterology

Volumn 23, Issue 5, 2012, Pages 604-607

  Yalav, Orçun ^a   Yaǧmur, Özgür ^a   Ülkü, Abdullah ^a   Akcam, AtilganTolga ^a   Sönmez, Hüsnü ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Endemic zoonotic disease; Fasciola hepatica; Obstructive jaundice

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; TRICLABENDAZOLE;

ABDOMINAL PAIN; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT BYPASS; BILE DUCT CARCINOMA; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLECYSTECTOMY; COMMON BILE DUCT; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; EOSINOPHILIA; FASCIOLA HEPATICA; FASCIOLIASIS; FECES ANALYSIS; FEMALE; FEVER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMAGGLUTINATION TEST; HUMAN; HUMAN TISSUE; JAUNDICE; LAPAROTOMY; LIVER BIOPSY; MAGNETIC RESONANCE IMAGING UNIT; OBSTRUCTIVE JAUNDICE; SINGLE DRUG DOSE; T TUBE;

ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BIOPSY; CHOLANGIOCARCINOMA; COMMON BILE DUCT; DIAGNOSIS, DIFFERENTIAL; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; HUMANS; JAUNDICE, OBSTRUCTIVE; MAGNETIC RESONANCE IMAGING; MIDDLE AGED;

EID: 84871105112     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2012.0420     Document Type: Article

References (22)

1. Turhan ÖA. Seroepidemiology of Fasciola hepatica in the province of Antalya. Uzmanlik Tezi (PhD thesis), Antalya, Akdeniz Üniversitesi Tip Fakültesi İnfeksiyon Hastaliklari ve Klinik Mikrobiyoloji, 2002.
2. Ozturhan H, Emekdaş G, Sezgin O, et al. Seroepidemiology of Fasciola hepatica in Mersin province and surrounding towns and the role of family history of the fascioliasis in the transmission of the parasite. Turk J Gastroenterol 2009; 20: 198-203.
3. Sezgin O, Altintas E, Disibeyaz S, et al. Hepatobiliary fascioliasis: clinical and radiologic features and endoscopic management. J Clin Gastroenterol 2004; 38: 285-90.
4. Mas-Coma S. Epidemiology of fascioliasis in human endemic areas. J Helminthol 2005; 79: 207-16. (Pubitemid 41192534)
5. Karabuli TA, Shaikhani MA, Karadaghi SH, Kasnazan KH. Education and imaging. Hepatobiliary and pancreatic: Fascioliasis. J Gastroenterol Hepatol 2009; 24: 1309.
6. Marcos L, Maco V, Samalvides F, et al. Risk factors for Fasciola hepatica infection in children: a case-control study. Trans R Soc Trop Med Hyg 2006; 100: 158-66. (Pubitemid 43024772)
7. Fried B, Abruzzi A. Food-borne trematode infections of humans in the United States of America. Parasitol Res 2010; 106: 1263-80.
8. Caprino P, Ferranti Passa G, Quintiliani A. A rare case of obstructive jaundice and cholecystitis in hepatic fascioliasis in Italy. Chir Ital 2007; 59: 891-4.
9. Dobrucali A, Yigitbasi R, Erzin Y, et al. Fasciola hepatica infestation as a very rare cause of extrahepatic cholestasis. World J Gastroenterol 2004; 10: 3076-7. (Pubitemid 39303069)
10. Moghadami M, Mardani M. Fasciola hepatica: a cause of obstructive jaundice in an elderly man from Iran. Saudi J Gastroenterol 2008; 14: 208-10.
11. Danilewitz M, Kotfila R, Jensen P. Endoscopic diagnosis and management of Fasciola hepatica causing biliary obstruction. Am J Gastroenterol 1996; 91: 2620-1. (Pubitemid 26406326)
12. Kim YH, Kang KJ, Kwon JH. Four cases of hepatic fascioliasis mimicking cholangiocarcinoma. Korean J Hepatol 2005; 11: 169-75.
13. Valero MA, Perez-Crespo I, Periago MV, et al. Fluke egg characteristics for the diagnosis of human and animal fascioliasis by Fasciola hepatica and F. gigantica. Acta Trop 2009; 111: 150-9.
14. Espinoza JR, Maco V, Marcos L, et al. Evaluation of Fas2-ELISA for the serological detection of Fasciola hepatica infection in humans. Am J Trop Med Hyg 2007; 76: 977-82. (Pubitemid 351627690)
15. Apt W, Aguilera X, Vega F, et al. Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. Am J Trop Med Hyg 1995; 52: 532-53.
16. Gonzalo-Orden M, Millan L, Alvarez M, et al. Diagnostic imaging in sheep hepatic fascioliasis: ultrasound, computer tomography and magnetic resonance findings. Parasitol Res 2003; 90: 359-64. (Pubitemid 36995189)
17. Behar JM, Winston JS, Borgstein R. Hepatic fascioliasis at a London hospital - the importance of recognising typical radiological features to avoid a delay in diagnosis. Br J Radiol 2009; 82: e189-93.
18. Roses LP, Alonso D, Iniguez F, et al. Hepatic fascioliasis of long-term evaluation: diagnosis by ERCP. Am J Gastroenterol 1993; 88: 2118-9. (Pubitemid 23352188)
19. Ezzat RF, Karboli TA, Kasnazani KA, et al. Endoscopic management of biliary fascioliasis: a case report. AM. J Med Case Reports 2010; 4: 83.
20. Keiser J, Engels D, Buscher G, Utzinger J. Triclabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opin Investig Drugs 2005; 14: 1513-26. (Pubitemid 41749196)
21. Talaie H, Emami H, Yadegarinia D, et al. Randomized trial of a single, double and triple dose of 10 mg/kg of a human formulation of triclabendazole in patients with fascioliasis. Clin Exp Pharmacol Physiol 2004; 31: 777-82. (Pubitemid 39556852)
22. Toner E, Brennan GP, McConvery F, et al. A transmission electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica. Parasitology 2010; 137: 855-70.